A Registry Study to Describe the Implications of Therapeutic Management of Etanercept in Patients With Rheumatoid Arthritis.
Phase of Trial: Phase IV
Latest Information Update: 01 May 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer; Wyeth
- 07 Jun 2017 Biomarkers information updated
- 07 Feb 2012 Actual number of patients changed from 500 to 441 as reported by ClinicalTrials.gov.
- 07 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.